IPP Bureau
SIMS Hospital, Chennai perform rare jaw surgeries
By IPP Bureau - August 23, 2021
Surgeries for the replacement of hip and knee joints have become common, the ones for the replacement of jaw joints and the use of 3D printed custom-made joints are new
Pfizer receives EC approval for XEIJANZ
By IPP Bureau - August 23, 2021
XELJANZ is the first and only Janus kinase (JAK) inhibitor approved in Europe for the treatment of polyarticular JIA and juvenile PsA and has received regulatory approval in four indications in the European Union, the most of any JAK inhibitor
Vivera Pharmaceuticals gets US patent for ZICOH
By IPP Bureau - August 23, 2021
The software enables real-time communication between patients, caregivers, physicians, and pharmacists and each cartridge in the device has a unique, traceable serial number registered to the patient
Zydus gets USFDA approval for arthritis drug
By IPP Bureau - August 23, 2021
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Covid-19 severity screening method developed
By IPP Bureau - August 23, 2021
Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer
Quess Corp launch healthcare vertical, signs MoU with AHPI
By IPP Bureau - August 23, 2021
It aims to provide trained healthcare manpower, home care solutions, and end-to-end hospital management services enabling quick & on-demand deployment
QubeHealth ties up with OboPay for seamless medical credit
By IPP Bureau - August 23, 2021
Employees of QubeHealth’s corporate clients draw as much money as they need to instantly pay for any medical emergencies or regular healthcare payments
USFDA grants full approval for Pfizer-BioNTech Covid-19 vaccine
By IPP Bureau - August 23, 2021
The vaccine will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of Covid-19 disease
Aurobindo Pharma calls off its acquisition of Cronus Pharma
By IPP Bureau - August 21, 2021
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
Apollo Hospital Chennai launch Hernia Care Centre
By IPP Bureau - August 21, 2021
This brings hope for patients suffering from all types of hernia, as the centre has a replenished armamentarium of technology and techniques to produce a good outcome
.jpg "Emcure Pharma files DRHP for proposed IPO, offer size in the range Rs 4,500-5000 crores")
Emcure Pharma files DRHP for proposed IPO, offer size in the range Rs 4,500-5000 crores
By IPP Bureau - August 20, 2021
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
HealthCare at Home acquires SuVitas
By IPP Bureau - August 20, 2021
The acquisition expands the company’s service portfolio in the transition care segment
Kauvery hospitals rope in Ms Dhoni as brand ambassador
By IPP Bureau - August 20, 2021
Kauvery group of hospitals, a leading healthcare chain in Tamil Nadu, has roped in former Indian cricket captain Mahendra Singh Dhoni as its brand ambassador
Jehangir Hospital launches upgraded centre for Endoscopy
By IPP Bureau - August 20, 2021
The Endosonography allows the use of EUS guided Fine needle aspiration for accurate diagnosis of GI cancers without the need for conventional biopsies
US FDA approves Jardiance to treat adults living with heart failure with a reduced ejection fraction
By IPP Bureau - August 20, 2021
New treatment options are critical, as approximately half of all people with heart failure die within five years of diagnosis. Heart failure accounts for more than one million hospitalisations a year in the US
